Markel Group Inc. Common Stock (MKL) : juste valeur

Thèse ACCE

Markel Group writes specialty commercial insurance (excess and surplus lines, programs, and reinsurance) and owns a portfolio of operating businesses, including Markel Ventures, plus a large equity investment book inherited from its history as a Berkshire-style holding company. The core edge is underwriting discipline in niche property and casualty lines, where pricing power and specialist expertise let it earn returns that generalist carriers often miss. Revenue grew 12.7% and the operating margin is 30.1%, which is strong for a P&C insurer, while the trailing P/E of 9.9 sits well below the forward P/E of 15.9, a gap that suggests earnings were depressed in the recent base period and the market is pricing a recovery. The stock looks cheap on trailing earnings but not on forward estimates, so the question for a PM is whether the 12.5% ROE can rise as the insurance cycle and the investment book normalize. It is worth a deeper look for the underwriting track record and the sensitivity of earnings to catastrophe losses and reserve development, which the data here does not capture.